Biotech & Life Sciences investors in Switzerland

    24 funds

    Gatsbie lists 24 Biotech & Life Sciences investors headquartered in Switzerland (as of 2026-10-24).

    17 name biotech & life sciences in their investment focus; 7 invest across sectors.

    Most are based in Zug (7), Zurich (4) and Zürich (4); the most common stages are Seed (13), Series A (12) and Growth (9); the most common kinds of capital are Venture equity (18), Buyout (16) and Growth equity (14).

    20 of 24 funds

    1. 3T Family Office Ltd

      Geneva, Switzerland

      Stages: Pre-Seed, Seed, Series A, Series B

      Sectors: Financial Services, Healthcare & MedTech, Consumer Apps, Media & Entertainment

    2. Blue Horizon

      Zurich, Switzerland

      Stages: Seed

      Sectors: Biotech & Life Sciences, AgTech & FoodTech, Artificial Intelligence

    3. CC TRUST GROUP AG

      Baar, Switzerland

      Stages: Mature

      Sectors: Financial Services, Healthcare & MedTech, PropTech, Space & Aerospace

    4. CC TRUST GROUP AG / CLAUDIO CISULLO

      Baar, Switzerland

      Stages: Mature

      Sectors: Hardware & IoT, Biotech & Life Sciences, PropTech, Financial Services

    5. EISVOGEL GROUP AG

      Zug, Switzerland

      Stages: Growth, Mature

      Sectors: Enterprise Software, Healthcare & MedTech, Hardware & IoT, Artificial Intelligence

    6. HBM Healthcare Investments

      Zug, Switzerland

      Stages: Pre-Seed, Seed, Series A, Series B

      Sectors: Hardware & IoT, Healthcare & MedTech, Biotech & Life Sciences

    7. INTERGROUP PARTNERS AG

      Schindellegi, Switzerland

      Stages: Seed, Series C+

      Sectors: Cybersecurity, Developer Tools, Space & Aerospace, Hardware & IoT

    8. Nextech Invest Ltd.

      Zürich, Switzerland

      Stages: Series A, Series B, Series C+

      Sectors: Biotech & Life Sciences, Hardware & IoT, Healthcare & MedTech, Mobility & Transportation

    9. Novastone Capital Advisors

      Zug, Switzerland

      Stages: Mature

      Sectors: CleanTech & Climate, AgTech & FoodTech, Biotech & Life Sciences

    10. Redalpine Venture Partners AG

      Zürich, Switzerland

      Stages: Pre-Seed, Seed, Series A, Series C+

      Sectors: Biotech & Life Sciences, Healthcare & MedTech, Hardware & IoT, CleanTech & Climate

    11. SHILOH ADVISORS AG

      Zug, Switzerland

      Stages: Pre-Seed

      Sectors: Healthcare & MedTech, AgTech & FoodTech, Artificial Intelligence, PropTech

    12. Alpana Ventures

      Geneva, Switzerland

      Stages: Pre-Seed, Seed, Series A, Series B

      Sectors: Healthcare & MedTech, Financial Services, Data & Analytics, Enterprise Software

    13. ANDREAS STRÜNGMANN / SANTO HOLDING

      Zug, Switzerland

      Stages: Others

      Sectors: Hardware & IoT, Healthcare & MedTech, Biotech & Life Sciences

    14. BB Biotech Ventures

      Kusnacht, Switzerland

      Stages: Pre-Seed, Seed, Series A, Growth

      Sectors: Hardware & IoT, Biotech & Life Sciences, Healthcare & MedTech, HR Tech

    15. BiomedVC

      Basel, Switzerland

      Stages: Pre-Seed, Seed, Series A, Series B

      Sectors: Hardware & IoT, Biotech & Life Sciences, Healthcare & MedTech

    16. HBM Partners

      Zug, Switzerland

      Stages: Pre-Seed, Seed, Series A, Series B

      Sectors: Healthcare & MedTech, Hardware & IoT, Biotech & Life Sciences

    17. Philos & Partners

      Zurich, Switzerland

      Stages: Others

      Sectors: Hardware & IoT, Healthcare & MedTech, Biotech & Life Sciences

    18. Abegg & Co AG

      Zürich, Switzerland

      Stages: Growth, Mature

      Sectors: Others

    19. BERGOS AG

      Zurich, Switzerland

      Stages: Seed, Series A, Series B

      Sectors: Others

    20. CIGP - COMPAGNIE D'INVESTISSEMENTS ET DE GESTION PRIVÉE

      Geneva, Switzerland

      Stages: Seed

      Sectors: Others

    See all 24 Biotech & Life Sciences investors in Investor Discovery

    Biotech & Life Sciences investors elsewhere

    Other sectors in Switzerland

    Counted by where each fund is headquartered, from public sources, as of 2026-10-24. Funds that invest across sectors are included, as in Investor Discovery.